Document Detail


Angiotensin-converting enzyme inhibition and radial artery compliance in patients with congestive heart failure.
MedLine Citation:
PMID:  7649587     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Congestive heart failure is characterized by a clear-cut impairment of arterial compliance of medium-sized arteries, but whether this alteration is irreversible or can be favorably affected by cardiovascular drugs currently used in congestive heart failure treatment is unknown. We studied 9 congestive heart failure patients (New York Heart Association class II; age, [mean +/- SEM] 60.7 +/- 3.3 years) receiving diuretic and digitalis treatment in whom arterial compliance was assessed at the level of the radial artery by an echotracking device capable of measuring the arterial diameter along the entire cardiac cycle. Beat-to-beat arterial blood pressure was concomitantly measured by a Finapres device that allowed diameter-pressure curves and compliance-pressure curves (Langewouters' formula) to be calculated for the entire systolic-diastolic blood pressure range. Arterial compliance was expressed as the area under the compliance-pressure curve normalized for pulse pressure (compliance index). Data were collected before and after 4 and 8 weeks of oral administration of benazepril (10 mg/day). Ten healthy subjects were studied before and after an observational period of 4 weeks (5 subjects) or 8 weeks (5 subjects), and 9 age-matched mildly essential hypertensive subjects studied before and after 4 to 12 weeks of benazepril administration served as control subjects. In congestive heart failure patients, baseline compliance index was significantly less than in normotensive and hypertensive subjects. However, the compliance index showed a marked increase after 4 weeks of benazepril administration (+95.7 +/- 24.9%, P < .05); the increase was also marked after 8 weeks of angiotensin-converting enzyme inhibitor treatment (+77.7 +/- 4.2%, P < .05).(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
C Giannattasio; M Failla; M L Stella; A A Mangoni; D Turrini; S Carugo; M Pozzi; G Grassi; G Mancia
Related Documents :
2541177 - Comparison of once-daily captopril or enalapril in mild essential hypertension.
1480537 - Absence of potentiation of the skin response to intradermal bradykinin by a long-acting...
6137387 - Captopril combined with minoxidil, beta-blocker and furosemide in the treatment of refr...
2843197 - Pharmacokinetics of single and consecutive doses of cilazapril and its depressor effect...
3793197 - Comparison of 1-hour and 24-hour blood pressure recordings in central or peripheral bar...
3928257 - Hemodynamic effects of positive end-expiratory pressure during high-frequency ventilation.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Hypertension     Volume:  26     ISSN:  0194-911X     ISO Abbreviation:  Hypertension     Publication Date:  1995 Sep 
Date Detail:
Created Date:  1995-09-28     Completed Date:  1995-09-28     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7906255     Medline TA:  Hypertension     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  491-6     Citation Subset:  IM    
Affiliation:
Cattedra di Medicina Interna, Università di Milano, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Angiotensin-Converting Enzyme Inhibitors / pharmacology*
Benzazepines / pharmacology*
Compliance
Female
Heart Failure / physiopathology*
Humans
Male
Middle Aged
Pressoreceptors / drug effects,  physiology
Radial Artery / drug effects,  physiopathology*
Reflex / drug effects
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Benzazepines; 86541-75-5/benazepril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and c...
Next Document:  Postischemic blood flow response in hypercholesterolemic patients.